While the prevalence of chronic diseases boosts the demand for self-administered treatments, ease of use is becoming more important in device manufacturing, says product specialist.
According to a new report, the market for needle-free injection
devices and safety syringes will exceed $2.49bn (€2.1bn) by 2009,
buoyed on by the increase of incidences in needlestick injuries and
high consumer demand for syringe...
A patent covering a simple design for a safety syringe, which uses
a vacuum rather than a spring to retract the needle after use and
should be cheaper to manufacture than current products, has been
filed in the US by Maxxon Inc.
Italy's Marchesini has introduced a new packaging system that can
handle safety syringes, which are underused in Europe compared to
the US despite their proven benefits in reducing needlestick
injuries, reports Phil Taylor. It...
Gaining ground in the billion dollar safety needles and syringes
market US development stage company Maxxon has linked up with Texan
drug delivery manufacturer Globe Medical Tech for a run on millions
of syringes.